Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07384013 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Evaluation of the Effect of metamizole (Optalgin®) on Anti-Xa Levels in Oncology Patients Receiving Direct Oral Anticoagulants (DOACs)
Trial Details
NCT Number NCT07384013
Lead Sponsor Rambam Health Care Campus
Conditions
(from sponsor)
Oncologic Diseases, Coagulation Defect, Pain Management
Related terms Agnosia, Hemostatic Disorders
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov